We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.71%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
+$684M
(+16%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
8.22%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
1,104
New
355
Increased
287
Reduced
198
Closed
246
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$115M |
| 2 |
Bausch Health
BHC
|
+$84M |
| 3 |
Brookdale Senior Living
BKD
|
+$72M |
| 4 |
Abbott
ABT
|
+$56.3M |
| 5 |
AET
Aetna Inc
AET
|
+$56.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$160M |
| 2 |
Perrigo
PRGO
|
+$122M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$115M |
| 4 |
Amgen
AMGN
|
+$82M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$36.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.19% |
| 2 | Miscellaneous | 8.84% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Consumer Staples | 5.73% |
| 5 | Utilities | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
151
Amarin Corp
AMRN
$294M
| $6.5M | 0.13% |
165,000
+163,394
| +10,174% | +$8.46M |
|
152
Veracyte
VCYT
$3.23B
| $6.48M | 0.13% |
+447,050
| New | +$5.82M |
|
|
UNS
153
DELISTED
UNS ENERGY CORP COM
UNS
| $6.43M | 0.13% |
+107,474
| New | +$5.41M |
|
154
Apple
AAPL
$4.84T
| $6.35M | 0.12% |
316,848
-126,308
| -29% | -$2.39M |
|
155
Estee Lauder
EL
$34.8B
| $6.24M | 0.12% |
82,901
+31,222
| +60% | +$2.26M |
|
156
Globus Medical
GMED
$10B
| $6.24M | 0.12% |
309,142
+108,716
| +54% | +$2.02M |
|
157
Canadian Natural Resources
CNQ
$106B
| $6.23M | 0.12% |
+380,948
| New | +$5.92M |
|
158
Cigna
CI
$76.3B
| $6.2M | 0.12% |
70,915
+60,454
| +578% | +$4.95M |
|
159
Target
TGT
$70.1B
| $6.2M | 0.12% |
98,010
+88,909
| +977% | +$5.68M |
|
|
AWAY
160
DELISTED
HOMEAWAY INC COM
AWAY
| $6.17M | 0.12% |
151,013
-50,933
| -25% | -$1.74M |
|
161
Patterson-UTI
PTEN
$4.85B
| $6.13M | 0.12% |
+242,027
| New | +$5.79M |
|
|
DRC
162
DELISTED
DRESSER-RAND GROUP INC
DRC
| $6.12M | 0.12% |
+102,693
| New | +$6.09M |
|
|
SVA
163
DELISTED
Sinovac Biotech, Ltd
SVA
| $6.12M | 0.12% |
1,000,000
| – | – |
|
|
AUY
164
DELISTED
Yamana Gold, Inc.
AUY
| $6.11M | 0.12% |
709,300
+570,000
| +409% | +$5.26M |
|
165
Eastman Chemical
EMN
$7.53B
| $6.1M | 0.12% |
75,600
+32,266
| +74% | +$2.51M |
|
|
FRGI
166
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $6.1M | 0.12% |
+116,702
| New | +$5.21M |
|
|
HNT
167
DELISTED
HEALTH NET INC
HNT
| $6.05M | 0.12% |
203,800
-603,920
| -75% | -$18.1M |
|
168
Valero Energy
VLO
$114B
| $5.99M | 0.12% |
118,789
+72,056
| +154% | +$3.04M |
|
|
DOOR
169
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $5.92M | 0.12% |
+98,747
| New | +$4.98M |
|
170
Suncor Energy
SU
$84.1B
| $5.92M | 0.12% |
+168,872
| New | +$5.94M |
|
171
Vodafone
VOD
$40.9B
| $5.9M | 0.12% |
147,132
-74,987
| -34% | -$2.82M |
|
172
Eli Lilly
LLY
$1.01T
| $5.88M | 0.12% |
115,257
+4,345
| +4% | +$218K |
|
|
NBL
173
DELISTED
Noble Energy, Inc.
NBL
| $5.86M | 0.12% |
+86,057
| New | +$6.1M |
|
|
AIRM
174
DELISTED
Air Methods Corp
AIRM
| $5.83M | 0.11% |
99,941
+16,034
| +19% | +$799K |
|
175
Arrowhead Research
ARWR
$9.98B
| $5.82M | 0.11% |
+536,032
| New | +$4.29M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Visium Asset Management held 1,104 positions worth $5.09B, up 16% from $4.41B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Visium Asset Management deployed $419M of net new capital in Q4 2013, opening 355 new positions and adding to 287 existing holdings. Its largest new stake was Bausch Health: 766,970 shares worth $90M.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 55% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $122M trimmed.
- Visium Asset Management's largest Q4 2013 buy was Bausch Health: 766,970 shares worth $90M.
- Visium Asset Management added most to Allergan plc in Q4 2013, an estimated $115M increase.
- Visium Asset Management's biggest Q4 2013 reduction was Perrigo, cutting an estimated $122M.
- Visium Asset Management fully exited WARNER CHILCOTT PLC ORD SHS CL A (IRL) in Q4 2013, selling an estimated $160M.
- Visium Asset Management's ten largest holdings make up 29% of its $5.09B portfolio in Q4 2013.
- Visium Asset Management opened 355 new positions and closed 246 in Q4 2013.
- Visium Asset Management's portfolio value rose 16% quarter-over-quarter to $5.09B.
Based on Visium Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.